00:00 What are the challenges facing the women in the EU?
00:04 First of all, a cultural evolution issue, frankly.
00:08 To work to remove the obstacles that arise today,
00:12 both to achieve a complete salary equality,
00:17 and on the other hand, to offer opportunities to women
00:20 who were not hindered by their daily reality.
00:23 In particular, in our case, I wanted to say,
00:25 to eliminate any distinctions through parental leave,
00:30 between the impact of having a son,
00:32 which is an important moment in the life of a family,
00:35 that has no impact on the man and the woman in their career development.
00:39 The responsibility of those who work in a fortunate sector,
00:41 such as the pharmaceutical sector, in companies like multinationals,
00:44 who have the possibility of having important global benchmarks.
00:50 This gives us the responsibility to do a little business,
00:53 and to set an example on how to achieve a complete equality from all points of view.
00:58 It was a year of great success from many points of view.
01:01 It was a year of success, first of all, in research.
01:04 We published at least 10 important clinical studies results
01:09 on innovative drugs with a potential impact in the oncological area,
01:13 in the cardiovascular area, in the immunology area.
01:16 And it was also a year of great financial satisfaction,
01:18 both for Novartis Italy and for the company at a global level.
01:22 The prospects related to these publications,
01:25 which I referred to, are those of arriving with new drugs
01:29 that will obtain a refund this year.
01:32 Drugs in the area of the mammary tumor, for example,
01:35 as well as in the area of the prostate tumor.
01:38 So in the oncological area, an important year,
01:40 but also in the other four areas in which we are active,
01:44 cardiovascular, immunology and neuroscience.
Comments